How AOD-9604 works (mechanism, in plain clinical terms) The simplest way to understand AOD-9604 is this: GLP-1s help many patients eat less and improve glycemic control
Conclusion Ipamorelin represents a highly selective growth hormone secretagogue with receptor specificity that enables effective GH stimulation without substantial activation of other endocrine pathways
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells
Positioning, supportive pillows, ice or heat before bed reducing nighttime discomfort
Associated datasets are provided in Supplementary Tables 14, 67 and 912